Kazia Therapeutics Limited
Last updated September 27, 2026
Organization details
- Legal name
- Kazia Therapeutics Limited
- Former names
- Novogen Ltd
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Australia
- Headquarters city
- Sydney NSW
- Headquarters country
- Australia
- Fiscal year end
- June
- Ticker symbol
- KZIA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001075880
Board of directors
-
Ebru Davidson · DirectorSince 2026
-
Robert F. Apple · DirectorSince 2026
-
Steven R. S. Coffey · DirectorSince 2026
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Kazia Therapeutics Limited
How many directors are on Kazia Therapeutics Limited's board?
Kazia Therapeutics Limited's board has 3 directors: Ebru Davidson, Robert F. Apple and Steven R. S. Coffey.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="kazia-therapeutics-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.